Summary & Overview
CPT 48556: Donor Pancreas Explantation for Graft Failure
CPT code 48556 represents the surgical explantation of a previously transplanted donor pancreas when the graft fails to function. This code captures a complex, high-acuity operative service most commonly performed in the inpatient hospital setting and is relevant to transplant programs, hospital billing departments, and payers managing post-transplant complications. Nationally, pancreas graft failure and subsequent explant procedures carry significant clinical and resource implications for transplant centers and payers, including intensive perioperative care and potential impacts on readmission and length-of-stay metrics. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for pancreas explantation, typical sites of service, common payer coverage considerations, and benchmarking topics including utilization patterns and reimbursement factors where available. The publication also summarizes common modifier usage and highlights areas where additional coding detail or diagnosis linkage is often needed. Data not available in the input is explicitly noted where applicable.
Billing Code Overview
CPT code 48556 describes the surgical removal of a previously transplanted donor pancreas when the transplanted organ fails to function normally. This procedure involves explantation of the donor pancreas and related operative management.
-
Service type: Surgical procedure (organ explantation)
-
Typical site of service: Inpatient hospital operating room or other inpatient surgical setting
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient with a history of simultaneous pancreas-kidney transplantation presents months after transplant with progressive graft dysfunction characterized by persistent hyperglycemia, recurrent infections localized to the graft site, and imaging evidence of graft necrosis and fistula formation. The patient is admitted to a tertiary care transplant center. The transplant surgery team evaluates the patient, obtains preoperative labs (CBC, CMP, coagulation studies), crossmatch and infectious workup, and imaging (CT abdomen/pelvis with contrast). After multidisciplinary review including transplant nephrology and infectious disease, the decision is made to remove the failing donor pancreas (explant) due to irreversible graft failure, sepsis risk, or refractory graft pancreatitis.
The clinical workflow includes preoperative optimization (antibiotics if infected, adjustment of immunosuppression), informed consent specifying risks of explantation and potential impact on diabetes management, scheduling in the operating room with general anesthesia, intraoperative explant of the donor pancreas (often via laparotomy), hemostasis and possible drainage placement, and postoperative monitoring in a recovery or surgical ward with attention to fluid status, glycemic control, wound care, and immunosuppression adjustments. Documentation must identify the removed organ as a previously transplanted donor pancreas. Billing and coding use 48556 for removal of a previously transplanted donor pancreas when performed because of graft failure or complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|